Health Care/Hospital
AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery
SHANGHAI, Oct. 31, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychia...
2023-10-31 09:35
1676
SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit
Preclinical data show SK Life Science Labs compounds have robust anti-tumor efficacy in vivo and oral leads have demonstrated potent selective degradation of SMARCA2 with selective inhibition of proliferation of SMARCA4 mutant cells KING OF PRUSSIA, Pa., Oct. 31, 2023 /PRNewswire/ -- SK Life Scie...
2023-10-31 08:00
1401
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC
SEONGNAM, South Korea and NEWTON, Mass., Oct. 30, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced that the company has initiated the Phase 1/2 clinical trial evaluating t...
2023-10-31 07:00
1139
LifeSpan Vision Ventures Invests in NaNotics
NORWALK, Conn., Oct. 31, 2023 /PRNewswire/ -- LifeSpan Vision Ventures, an investment firm dedicated to longevity biotech, today announced an investment in NaNotics LLC. This preclinical-stage biopharmaceutical company is developing NaNots™, novel subtractive nanoparticles that treat disease by c...
2023-10-31 02:26
1772
Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results
SHENZHEN, China, Oct. 30, 2023 /PRNewswire/ -- Pulsecare Medical, an innovative minimally invasive and non-invasive therapeutic technology company, announced today that its nanosecond pulsed field ablation (nsPFA) system for cardiac electrophysiology, the world's first third-generation pulsed fie...
2023-10-30 23:02
1309
AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023
* Recently achieved MDSAP certification and ISO/IEC 27001, 27017, 27018 certifications, paving the way for accelerated expansion into global markets. * Certified Japan's Pharmaceuticals and Medical Devices Agency (PMDA), signaling the beginning of its full-scale expansion into the Japanese mar...
2023-10-30 23:00
1531
Huawei's new Health Lab in Finland is Advancing Global Efforts in Health & Fitness Research
HELSINKI, Oct. 30, 2023 /PRNewswire/ -- Huawei launched a new HUAWEI Health Lab located inHelsinki, Finland. Equipped with state-of-the-art testing equipment, the laboratory serves as the research platforms for Huawei's health & fitness sector. Sized at almost 1000 square metres, the laboratory ...
2023-10-30 22:25
1926
Olight 2023 Breast Cancer Charity Campaign: Illuminating Hope with Breast Cancer Foundations Across the World
FRISCO, Texas, Oct. 30, 2023 /PRNewswire/ -- Olight, a leading mobile lighting manufacturer, successfully concludes its 2023 Breast Cancer Charity Campaign, raising$77,313.43 for breast cancer support across 13 countries, including the USA, UK, Canada, Korea, Thailand, Italy, Germany, France, Aus...
2023-10-30 21:50
1651
NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer
National Comprehensive Cancer Network publishes free NCCN Guidelines for Patients with information on improving well-being and reducing suffering and distress for people with cancer; available atNCCN.org/patientguidelines. PLYMOUTH MEETING, Pa., Oct. 30, 2023 /PRNewswire/ -- The National Compreh...
2023-10-30 20:37
1455
WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth
* Revenue of RMB10,670 Million in the Third Quarter, Single Quarter Revenue Back to overRMB10 Billion; Revenue of RMB29,541 Million in the First Three Quarters, Up 4.0% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 23.4% * Net Profit Attributable to Owners of the Company for the ...
2023-10-30 20:01
2068
Journal of Thoracic Oncology Published Promising Results of Ivonescimab (PD-1/VEGF Bispecific) as First- or Second-line Therapy for Advanced or Metastatic Immunotherapy Naïve Non-Small-Cell Lung Cancer
HONG KONG, Oct. 30, 2023 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase Ib clinical trial for PD-1/VEGF bispecific antibody ( ivonecimab AK112/SMT112 ) as first- or second-line therapy for advanced or metastatic immunotherapy naïve non-small-cell lung cancer (NSCLC) were p...
2023-10-30 20:00
1962
New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance
RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures 1,5-anhydroglucitol, may be useful for evaluating short-term effectiveness and assessing patient compliance of SGLT-2 inhibitor diabetes drugs. SGLT-...
2023-10-30 20:00
1023
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
The partnership will further therapeutic and prophylactic vaccine development for the Chinese market and beyond. WOBURN, Ma. and SHENZHEN, China, Oct. 30, 2023 /PRNewswire/ -- Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreemen...
2023-10-30 19:30
1317
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program Targeting Alzheimer's and Other Tauopathy Diseases
New preclinical data presented at CTAD demonstrates exciting potential for a new drug approach for Alzheimer's disease, reducing brain tau pathology by ~70% CAMBRIDGE, Mass., Oct. 30, 2023 /PRNewswire/ -- Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic des...
2023-10-30 19:00
1133
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease
TAIPEI, Oct. 30, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company will be presenting at the American Heart Association (AHA) 2023 Annual Meeting taking place inPhiladelphia, PA, fromNovember 11-13, 2023. The presentation will focus on Foresee...
2023-10-30 15:18
1009
First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection
YANTAI, China, Oct. 30, 2023 /PRNewswire/ -- Boan Biotech (6955.HK) announced today that the first patient in Phase III clinical trial of its Nivolumab Injection (BA1104) inChina has been enrolled. BA1104 is the first biosimilar to Opdivo® to undergo a Phase III study in China. Nivolumab is a mo...
2023-10-30 14:51
1676
Pretty Beauty introduces SKIN AURA® bipolar radiofrequency instrument to enhance skin's fullness and contour
HONG KONG, Oct. 30, 2023 /PRNewswire/ -- To realise the dream of perfect skin for every lady, Pretty Beauty introduces the latest SKIN AURA® bipolar radiofrequency instrument, a beauty device launched byGermany's Wellcomet Technology. This instrument's care process starts by activating the fat la...
2023-10-30 14:40
1247
Alltech Joins Vital Group to Build an Industry Chain for High-End Medical Imaging
CHENGDU, China, Oct. 30, 2023 /PRNewswire/ -- On Oct. 28th, Alltech, a high-end medical imaging equipment developer under the umbrella of Vital Group, held a press conference titled "Joy of Life, Dream of Innovation" at the 88th China International Medical Equipment Fair (CMEF), where it announce...
2023-10-30 12:35
1894
Linq Wins Samsung Open Collaboration with LLM-Enhanced Underwriting AI Solution
SEOUL, South Korea, Oct. 30, 2023 /PRNewswire/ -- Linq, an AI startup, won first place in the 2023 Samsung Open Collaboration, one of the most prestigious startup competitions inSouth Korea. Linq showcased its AI-powered underwriting solution, which was made possible by its AI risk models and an ...
2023-10-30 08:11
1841
Innovent Announces Robust Weight Loss Efficacy, Multiple Metabolic Benefits and Favorable Safety Profile of Higher Dose 9 mg Mazdutide (IBI362) after 48-week Treatment in Phase 2 Study for Obesity
* Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumference, blood pressure, liver enzyme, triglyceride, low-density lipoprote...
2023-10-30 08:00
3340
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5328
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4437
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4028
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3185
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
2955